AI/ML Innovations Inc. Announces Proposed Private Placement
Rhea-AI Summary
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced a proposed non-brokered private placement of up to 6,000,000 units at $0.05 per unit, aiming to raise up to $300,000. Each unit consists of one common share and one warrant, exercisable at $0.10 per share for two years. The company plans to use the net proceeds for working capital requirements. The private placement is subject to regulatory approvals, including from the Canadian Securities Exchange. AI/ML Innovations focuses on artificial intelligence and machine learning in the digital health and wellbeing sector, with investments in Health Gauge, Tech2Heal, and AI Rx Inc.
Positive
- Potential to raise up to $300,000 for working capital
- Warrants provide potential for additional future funding at $0.10 per share
- Strategic focus on AI and ML in digital health sector
Negative
- Potential dilution of existing shareholders due to new share issuance
- Low unit price of $0.05 may indicate financial challenges or low market valuation
AI-generated analysis. How Rhea-AI works. Not financial advice.
VICTORIA, BC / ACCESSWIRE / August 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 6,000,000 units ("Units") at a price of
The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the CSE and applicable securities legislation.
The Company intends to use net proceeds of the Private Placement for working capital requirements.
The Company will pay a finder's fee to qualified finders who assist in selling the Units, in cash or securities or a combination of both, as permitted by CSE policy and applicable securities laws.
The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com